Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia

Name: Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia
Published: 2011
License: Public Domain

Jules Bordet Institute · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

acute myelogenous leukemia, myeloid leukemia in remission, effects of immunotherapy, wt1 positive acute myeloid leukemia, antigen specific cancer immunotherapeutic, ex vivo regulatory t cell depletion, in vivo regulatory t cell depletion, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia

Related documents